AAAAAA
Results: 1-25/26
Authors:
PARTRIDGE M
EMILION G
PATEROMICHELAKIS S
AHERN R
PHILLIPS E
LANGDON J
Citation: M. Partridge et al., ALLELIC IMBALANCE AT CHROMOSOMAL LOCI IMPLICATED IN THE PATHOGENESIS OF ORAL PRECANCER, CUMULATIVE LOSS AND ITS RELATIONSHIP WITH PROGRESSION TO CANCER, Oral Oncology, 34(2), 1998, pp. 77-83
Authors:
LANTZ J
AHERN R
Citation: J. Lantz et R. Ahern, RE-COLLECTION IN EXISTENTIAL PSYCHOTHERAPY WITH COUPLES AND FAMILIES DEALING WITH DEATH, Contemporary family therapy, 20(1), 1998, pp. 47-57
Authors:
GORE M
MAINWARING P
AHERN R
MACFARLANE V
SLEVIN M
HARPER P
OSBORNE R
MANSI J
BLAKE P
WILTSHAW E
SHEPHERD J
Citation: M. Gore et al., RANDOMIZED TRIAL OF DOSE-INTENSITY WITH SINGLE-AGENT CARBOPLATIN IN PATIENTS WITH EPITHELIAL OVARIAN-CANCER, Journal of clinical oncology, 16(7), 1998, pp. 2426-2434
Authors:
REES E
HARDY J
LING J
BROADLEY K
AHERN R
Citation: E. Rees et al., THE USE OF THE EDMONTON SYMPTOM ASSESSMENT SCALE (ESAS) WITHIN A PALLIATIVE CARE UNIT IN THE UK, Palliative medicine, 12(2), 1998, pp. 75-82
Authors:
ELLIS PA
SMITH IE
DETRE S
BURTON SA
SALTER J
AHERN R
WALSH G
JOHNSTON SRD
DOWSETT M
Citation: Pa. Ellis et al., REDUCED APOPTOSIS AND PROLIFERATION AND INCREASED BCL-2 IN RESIDUAL BREAST-CANCER FOLLOWING PREOPERATIVE CHEMOTHERAPY, Breast cancer research and treatment, 48(2), 1998, pp. 107-116
Authors:
TUTT ANJ
AHERN R
HENK JM
Citation: Anj. Tutt et al., CERVICAL NODE METASTASIS OF UNKNOWN PRIMARY SITE - THE ROYAL-MARSDEN-HOSPITAL 15 YEAR EXPERIENCE, British Journal of Cancer, 78, 1998, pp. 12-12
Authors:
DODDS RA
MINEHART H
JAMES LE
AHERN R
FARINA C
GOWEN M
Citation: Ra. Dodds et al., IN-SITU DEMONSTRATION OF SELECTIVE-INHIBITION OF THE OSTEOCLAST V-ATPASE USING A NOVEL INHIBITOR, Journal of bone and mineral research, 12, 1997, pp. 368-368
Authors:
MCCREADY R
AHERN R
Citation: R. Mccready et R. Ahern, A MORE RATIONAL BASIS FOR DETERMINING THE ACTIVITIES USED FOR RADIONUCLIDE IMAGING, European journal of nuclear medicine, 24(2), 1997, pp. 109-110
Authors:
MCCREADY R
AHERN R
Citation: R. Mccready et R. Ahern, QUALITY OF SUMMED SPET STUDIES IN RELATION TO PET - REPLY, European journal of nuclear medicine, 24(10), 1997, pp. 1329-1329
Authors:
CRAWFORD RAF
NEWLANDS E
RUSTIN GJS
HOLDEN L
AHERN R
BAGSHAWE KD
Citation: Raf. Crawford et al., GESTATIONAL TROPHOBLASTIC DISEASE WITH LIVER METASTASES - THE CHARING-CROSS EXPERIENCE, British journal of obstetrics and gynaecology, 104(1), 1997, pp. 105-109
Authors:
GORE M
AHERN R
SWENERTON K
Citation: M. Gore et al., GOOD MANNERS FOR THE PHARMACEUTICAL-INDUSTRY, Lancet, 350(9074), 1997, pp. 370-370
Authors:
ELLIS PA
SACCANIJOTTI G
CLARKE R
JOHNSTON SRD
ANDERSON E
HOWELL A
AHERN R
SALTER J
DETRE S
NICHOLSON R
ROBERTSON J
SMITH IE
DOWSETT M
Citation: Pa. Ellis et al., INDUCTION OF APOPTOSIS BY TAMOXIFEN AND ICI-182780 IN PRIMARY BREAST-CANCER, International journal of cancer, 72(4), 1997, pp. 608-613
Authors:
ABRAM P
AHERN R
BAUM M
BERSTOCK D
CAWTHORN S
COIBION M
FENNESSY M
HOUGHTON J
KISSIN M
LEE D
MACRAE K
MORITZ S
ODLINGSMEE W
PERRY M
RILEY D
SAUNDERS C
SAUVEN P
SMITH I
TEASDALE C
TOBIAS J
Citation: P. Abram et al., PRELIMINARY-RESULTS FROM THE CANCER-RESEARCH CAMPAIGN TRIAL EVALUATING TAMOXIFEN DURATION IN WOMEN AGED 50 YEARS OR OLDER WITH BREAST-CANCER, Journal of the National Cancer Institute, 88(24), 1996, pp. 1834-1839
Authors:
PAWSON R
AHERN R
CATOVSKY D
Citation: R. Pawson et al., 2ND MALIGNANCY IN HAIRY-CELL LEUKEMIA - NO EVIDENCE OF INCREASED INCIDENCE AFTER TREATMENT WITH INTERFERON-ALPHA, Leukemia & lymphoma, 22(1-2), 1996, pp. 103-106
Authors:
CORNER J
PLANT H
AHERN R
BAILEY C
Citation: J. Corner et al., NONPHARMACOLOGICAL INTERVENTION FOR BREATHLESSNESS IN LUNG-CANCER, Palliative medicine, 10(4), 1996, pp. 299-305
Authors:
GORE M
AHERN R
STANKIEWICZ M
SLEVIN M
Citation: M. Gore et al., TUMOR-MARKER LEVELS DURING MARIMASTAT THERAPY, Lancet, 348(9022), 1996, pp. 263-263
Authors:
MALLETT J
AHERN R
Citation: J. Mallett et R. Ahern, COMPARATIVE DISTRIBUTION AND USE OF HUMOR WITHIN NURSE-PATIENT COMMUNICATION, International journal of nursing studies, 33(5), 1996, pp. 530-550
Authors:
AHMED FY
LEONARD GA
AHERN R
TAYLOR AE
LORENTZOS A
ATKINSON H
MOORE J
NICOLSON MC
RICHES PG
GORE ME
Citation: Fy. Ahmed et al., A RANDOMIZED DOSE-ESCALATION STUDY OF SUBCUTANEOUS INTERLEUKIN-2 WITHAND WITHOUT LEVAMISOLE IN PATIENTS WITH METASTATIC RENAL-CELL CARCINOMA OR MALIGNANT-MELANOMA, British Journal of Cancer, 74(7), 1996, pp. 1109-1113
Authors:
HARDY JR
TURNER R
SAUNDERS M
AHERN R
Citation: Jr. Hardy et al., PREDICTION OF SURVIVAL IN A HOSPITAL-BASED CONTINUING CARE UNIT, European journal of cancer, 30A(3), 1994, pp. 284-288
Authors:
CHANG J
ATKINSON H
AHERN R
LORENTZOS A
GORE ME
Citation: J. Chang et al., A PHASE-II STUDY OF THE SEQUENTIAL ADMINISTRATION OF DACARBAZINE AND FOTEMUSTINE IN THE TREATMENT OF CEREBRAL METASTASES FROM MALIGNANT-MELANOMA, European journal of cancer, 30A(14), 1994, pp. 2093-2095
Authors:
RAYTER Z
GAZET JC
SHEPHERD J
TROTT P
SVENSSON W
AHERN R
Citation: Z. Rayter et al., EFFECTS OF TAMOXIFEN ON UTERUS, Lancet, 344(8922), 1994, pp. 624-624
Authors:
GORE M
BRIDGEWATER J
CHANG J
SCHOFIELD J
FISHER C
JACOBS I
PONDER B
AHERN R
MCKEAGE M
KELLAND L
HARRAP K
Citation: M. Gore et al., NONSURGICAL ASPECTS OF OVARIAN-CANCER, Lancet, 343(8893), 1994, pp. 335-340
Authors:
LANTZ J
AHERN R
Citation: J. Lantz et R. Ahern, MEANING AND THE FAMILY-LIFE CYCLE, Journal of religion and health, 33(2), 1994, pp. 163-172
Authors:
AHERN R
Citation: R. Ahern, THE ROLE OF STRATEGIC ALLIANCES IN THE INTERNATIONAL-ORGANIZATION OF INDUSTRY, Environment & planning A, 25(9), 1993, pp. 1229-1246
Authors:
AHERN R
Citation: R. Ahern, IMPLICATIONS OF STRATEGIC ALLIANCES FOR SMALL R-AND-D-INTENSIVE FIRMS, Environment & planning A, 25(10), 1993, pp. 1511-1526